Adela’s Co-Founder & Chief Scientific Officer, Dr. Daniel De Carvalho, Receives 2025 Canada Gairdner Momentum Award Recognizing World-Renowned Scientists for Exceptional Scientific Research Contributions with Continued Potential for Impact on Human Health | PR Newswire [Video]

The Canada Gairdner Awards celebrate the world’s best biomedical and global health researchers

, /PRNewswire/ — Adela, Inc. is proud to announce that Daniel De Carvalho, PhD, Co-Founder and Chief Scientific Officer, has been honored with the prestigious Peter Gilgan Canada Gairdner Momentum Award recognizing his outstanding scientific contributions, including early breakthroughs in methylation and the discovery of Adela’s best-in-class technology for blood-based cancer testing. Dr. De Carvalho’s contributions have the potential to transform cancer screening and surveillance by enabling earlier detection of many new and recurrent cancers with a blood test, resulting in more effective treatment.

The Canada Gairdner Awards recognize outstanding researchers whose unique scientific contributions have increased the understanding of human biology and disease. Since 1957, 426 awards have been bestowed on laureates from over 40 countries, and of those awardees, 102 have gone on to receive Nobel Prizes.

The Gairdner Foundation is recognizing Dr. De Carvalho as a …